India Generic Injectables Market PPT: Demand, Trends and Business Opportunities 2023-28

1
India Generic Injectables Market Research and
Forecast Report 2023-2028




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
India Generic Injectables Market Research Report
2023-2028 According to the latest report by
IMARC Group, titled "India Generic Injectables
Market Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2023-2028," the India
generic injectables market size reached US 2.4
Billion in 2022. A generic injectable is a drug
having the same pharmaceutical composition as its
branded counterpart in safety, strength, dosage
form, performance, quality, and route of
administration. It is cost-effective as generic
injectable does not have to undergo animal
testing and clinical studies to demonstrate
safety and effectiveness. As it also delivers the
same amount of active ingredients to the body,
the demand for generic injectables is rising
across India. Request for a PDF sample of this
report https//www.imarcgroup.com/india-generic-i
njectables-market/requestsample

4
Report Description and Highlights
Report Description
India Generic Injectables Market Trends The
growing prevalence of chronic diseases, such as
cancer, stroke, diabetes, septicemia, influenza
and pneumonia, and respiratory and Alzheimer's
disease, represents one of the key factors
driving the market in India. Moreover, the
Government of India is extensively investing in
research and development (RD) activities to
support the introduction of innovative generic
injectables and provide effective drug
administration, thereby enabling faster recovery
of patients. This, along with the expanding
healthcare industry, is contributing to the
growth of the market in the country. In addition,
technological advancements in the drug delivery
systems, such as the introduction of
self-injection devices, are positively
influencing the market. Besides this, the
increasing number of health insurance companies
in the country is offering lucrative growth
opportunities to industry investors.
Additionally, the rising awareness among the
masses about the benefits of using generic
injectables is propelling the growth of the
market in India. Apart from this, there is a rise
in the shortage of branded medicines and the
expiry of patents of branded items in the
country. This, coupled with the burgeoning life
science industry, is catalyzing the demand for
generic injectables. Furthermore, the
introduction of 3D printing technology in the
country that helps manufacture generic drugs with
varying release dates and tastes is bolstering
the growth of the market. Looking forward, IMARC
Group expects the market to reach US 4.9 Billion
by 2028, exhibiting a CAGR of 12.4 during the
forecast period (2023-2028). View Report TOC,
Figures and Tables https//www.imarcgroup.com/ind
ia-generic-injectables-market

5
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Therapeutic Area
• Oncology
• Anaesthesia
• Anti-infectives
• Parenteral Nutrition
• Cardiovascular
•  
• Breakup by Container
• Vials
• Ampoules
• Premix
• Prefilled Syringes
• Breakup by Distribution Channel
• Hospitals
• Retail Pharmacy

6
Report Description and Highlights
Report Description

• Breakup by Region
• North India
• West and Central India
• South India
• East India

7
Key Questions Answered in the Report
Report Description

•  
• How has the India generic injectables market
  performed so far and how will it perform in the
  coming years?
• What has been the impact of COVID-19 on the India
  generic injectables market?
• What are the key regional markets?
• What is the breakup of the market based on the
  therapeutic area?
• What is the breakup of the market based on the
  container?
• What is the breakup of the market based on the
  distribution channel?
• What are the various stages in the value chain of
  the industry?
• What are the key driving factors and challenges
  in the industry?
• What is the structure of the India generic
  injectables market and who are the key players?
• What is the degree of competition in the
  industry?
•  

8
Table of Contents
Report Description
1   Preface 2    Scope and Methodology     2.1
   Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3    Executive Summary4  
 Introduction    4.1    Overview    4.2    Key
Industry Trends5    India Generic Injectables
Market    5.1    Market Overview    5.2  
 Market Performance    5.3    Impact of
COVID-19    5.4    Market Forecast

9
Table of Contents
Report Description
6    Market Breakup by Therapeutic Area    6.1
   Oncology        6.1.1 Market Trends       
6.1.2 Market Forecast    6.2    Anaesthesia   
    6.2.1 Market Trends        6.2.2 Market
Forecast    6.3    Anti-infectives        6.3.1
Market Trends        6.3.2 Market Forecast    
6.4    Parenteral Nutrition        6.4.1 Market
Trends        6.4.2 Market Forecast     6.5  
 Cardiovascular        6.5.1 Market Trends     
  6.5.2 Market Forecast Click here to visit the
complete table of content with list of figures
and tables https//www.imarcgroup.com/india-gener
ic-injectables-market/toc

10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
13

Contact Us